JESSICA BELILL: Open Payments
NPI 1790407526 · MARLETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 32 payments from 8 companies in 2025. Trend: 2023 $69 · 2024 $157 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $159 |
| Axsome Therapeutics, Inc. | 4 | $83 |
| ABBVIE INC. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| PFIZER INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Exact Sciences Corporation | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: Wegovy, Auvelity, QULIPTA, REXULTI, NURTEC ODT, Rybelsus, Cologuard Collection Kit, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
